Evidence map›Paper›PMID 42272857›Full record

ArticleMicrobiome research reports2026

Dietary chicory rhamnogalacturonan-I modulates gut microbiota and immune responses in healthy adults.

Evangelia N Kerezoudi, Sue McKay, Seta Kurt, Maaike De Kreek, Jelle De Medts, Lynn Verstrepen, Jonas Ghyselinck, Lieven Van Meulebroek, Wim Calame, Ruud Albers and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiome research reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Evangelia N KerezoudiSchool of Medical Sciences, Örebro University, Örebro 70182, Sweden.
Sue McKayNutriLeads BV, Wageningen 6708 WH, The Netherlands.
Seta KurtDepartment of Clinical Research Laboratory, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro 70182, Sweden.
Maaike De KreekClinical and Experimental Endocrinology, KU Leuven, Leuven 3000, Belgium.
Jelle De MedtsProDigest BV, Zwijnaarde 9052, Belgium.
Lynn VerstrepenProDigest BV, Zwijnaarde 9052, Belgium.
Jonas GhyselinckProDigest BV, Zwijnaarde 9052, Belgium.
Lieven Van MeulebroekProDigest BV, Zwijnaarde 9052, Belgium.
Wim CalameStatistiCal BV, Wassenaar 2241 MN, The Netherlands.
Ruud AlbersNutriLeads BV, Wageningen 6708 WH, The Netherlands.
Annick MercenierNutriLeads BV, Wageningen 6708 WH, The Netherlands.
Robert J BrummerSchool of Medical Sciences, Örebro University, Örebro 70182, Sweden.
Ignacio RangelSchool of Medical Sciences, Örebro University, Örebro 70182, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bifidobacteriachicory root fibergut-immune axisprebioticrandomized controlled trialRhamnogalacturonan-I

Identifiers

PMID42272857
PMCPMC13246491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.